Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease
Kai-Chun Wu, Zhi Hua Ran, Xiang Gao, Minhu Chen, Jie Zhong, Jian-Qiu Sheng, Michael A Kamm, Simon Travis, Kori Wallace, Nael M Mostafa, Marisa Shapiro, Yao Li, Roopal B Thakkar, Anne M Robinson
Intestinal Research | KOREAN ASSOC STUDY INTESTINAL DISEASES | Published : 2016
AbbVie funded the study. AbbVie participated in the study design, data collection, data management, data analysis, review and approval of the publication. All authors were involved in the design of the analyses reported in the manuscript, interpretation of the data, and critical review and revision of each draft of the manuscript. All authors had access to relevant data and approved the content of the manuscript for submission. Medical writing support was provided by Adebusola A. Ajibade, PhD, of AbbVie Inc.